Literature DB >> 15289695

Management of pathologic fractures of the proximal femur: state of the art.

David J Jacofsky1, George J Haidukewych.   

Abstract

Metastases to bone are the most common cause of a destructive lesion of the skeleton in an adult. The proximal femur is the most commonly affected bone with metastatic disease in the appendicular skeleton. A systematic approach to patient management is critical, so as to avoid complications that will delay systemic therapy. The orthopedic traumatologist is often the first physician to see the patient with a pathologic fracture. As a result, the surgeon must be aware of the indications for resection versus internal fixation, as well as options for reconstruction. Polymethyl methacrylate and curettage can be useful in the appropriately selected patient. Postoperative external beam irradiation can significantly reduce disease progression and subsequent loss of fixation. A multidisciplinary approach to this patient group will help optimize prognosis as well as function. This article reviews the evaluation, management, and complications of treatment of pathologic fractures of the proximal femur, with an emphasis on metastatic disease and multiple myeloma.

Entities:  

Mesh:

Year:  2004        PMID: 15289695     DOI: 10.1097/00005131-200408000-00013

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN: 0890-5339            Impact factor:   2.512


  23 in total

1.  Metastatic disease of the long bones: a review of the health care burden in a major trauma centre.

Authors:  Michael Kelly; Mitchell Lee; Paul Clarkson; Peter J O'Brien
Journal:  Can J Surg       Date:  2012-04       Impact factor: 2.089

2.  Outcomes of a Modular Intercalary Endoprosthesis as Treatment for Segmental Defects of the Femur, Tibia, and Humerus.

Authors:  Joseph Benevenia; Rainer Kirchner; Francis Patterson; Kathleen Beebe; Dieter C Wirtz; Steven Rivero; Mark Palma; Max J Friedrich
Journal:  Clin Orthop Relat Res       Date:  2016-02       Impact factor: 4.176

3.  The Carbofix™ "Piccolo Proximal femur nail": A new perspective for treating proximal femur lesion. A technique report.

Authors:  Carmine Zoccali; Antonella Soriani; Barbara Rossi; Nicola Salducca; Roberto Biagini
Journal:  J Orthop       Date:  2016-07-06

4.  Surgery for pathological proximal femoral fractures, excluding femoral head and neck fractures: resection vs. stabilisation.

Authors:  Max Zacherl; Gerald Gruber; Mathias Glehr; Petra Ofner-Kopeinig; Roman Radl; Manfred Greitbauer; Vilmos Vecsei; Reinhard Windhager
Journal:  Int Orthop       Date:  2010-12-01       Impact factor: 3.075

5.  Surgical management of metastatic lesions of the proximal femur with pathological fractures using intramedullary nailing or endoprosthetic replacement.

Authors:  Zeping Yu; Yan Xiong; Rui Shi; Li Min; Wenli Zhang; Hongyuan Liu; Xiang Fang; Chongqi Tu; Hong Duan
Journal:  Mol Clin Oncol       Date:  2017-11-15

6.  [Surgical treatment of pathologic fractures of the humerus and femur].

Authors:  G Gruber; M Zacherl; A Leithner; C Giessauf; M Glehr; H Clar; R Windhager
Journal:  Orthopade       Date:  2009-04       Impact factor: 1.087

7.  Can certain benign lesions of the proximal femur be treated without surgery?

Authors:  Seung Han Shin; Ingwon Yeo; Sung Wook Seo
Journal:  Clin Orthop Relat Res       Date:  2013-05-14       Impact factor: 4.176

8.  [Management problems in the diagnostic work-up and treatment of pathological fracture of the proximal femur. Clinical case report].

Authors:  M Sass; I Melcher; K-D Schaser; G Stropahl; T Mittlmeier
Journal:  Unfallchirurg       Date:  2006-03       Impact factor: 1.000

9.  What Risks are Associated with Primary THA in Recipients of Hematopoietic Stem Cell Transplantation?

Authors:  Brian P Chalmers; Cameron K Ledford; Joseph M Statz; Tad M Mabry; Arlen D Hanssen; Matthew P Abdel
Journal:  Clin Orthop Relat Res       Date:  2016-08-19       Impact factor: 4.176

10.  A long femoral stem is not always required in hip arthroplasty for patients with proximal femur metastases.

Authors:  Zhiqing Xing; Bryan S Moon; Robert L Satcher; Patrick P Lin; Valerae O Lewis
Journal:  Clin Orthop Relat Res       Date:  2013-01-30       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.